COVID-19

From TMS as a treatment for long COVID to an update on 988 and crisis care, here are highlights from the week in Psychiatric Times.

Did you miss our APA Annual Meeting coverage?

Our 5 senses… are they under attack?

Many individuals infected with COVID-19 continue to experience symptoms after recovering from the initial viral infection. Persistent symptoms include neurocognitive and neuropsychiatric symptoms that can interfere with meaningful daily activities and roles. Given the symptom overlap, best practices and evidenced-based techniques for the treatment of concussion/mTBI can inform treatment approaches to manage symptoms and reduce the negative impact of long COVID.

The experts weighed in on a wide variety of psychiatric issues for the May 2023 issue of Psychiatric Times.

Research explores the differences between new-onset psychosis in patients with infection versus healthy controls.

From the relationship between social media and self-diagnosis to the FDA approval of the first treatment for agitation associated with Alzheimer disease dementia, here are highlights from the week in Psychiatric Times.

"It is essential to have an aggressive path forward to increase public awareness of mental health and illness, education on early intervention and treatment access, and continued destigmatization of mental illness."

Individuals with schizophrenia have experienced an increase in psychiatric, medical, and treatment risks because of the COVID-19 pandemic.

From collaborative care for individuals with schizophrenia and COVID-19 to strategies for building patient rapport, here are highlights from the week in Psychiatric Times.

How can patient-centered, collaborative care help promote safety and stabilization in the treatment of patients with cooccurring diagnoses of schizophrenia and COVID-19?

Catch up on the latest CMEs in Psychiatric Times.

How can we help primary care providers effectively manage mental health conditions in primary care settings?

It’s been 3 years since COVID-19 was declared a pandemic…

A patient loss does not undo or discard the multitude of meaningful life changing and life preserving work done.

“Bringing us home, To ourselves, Our selves, Our bodies, our shelters…”

Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?

The pandemic and its consequences aren’t over yet…

Revisiting the CME articles featured in Psychiatric Times in 2022.

Unity with the military helped a Northeastern Hospital during the COVID-19 pandemic.

"We must put mental health on par with physical health and make it a basic human right, an indicator of overall health, and an industry standard.”

"The cog in the wheel of treatment today is misinformation and lack of trust in the institutions of medicine, peer-reviewed published literature, the CDC, and pharmaceutical research."

From complementary and alternative approaches in the COVID-19 era to mental health’s most toxic myth, here are highlights from the week in Psychiatric Times.

In this CME article, explore the mental health consequences associated with the COVID-19 pandemic as well as the potential role for complementary and alternative approaches.

Mental health leads with 36% of all outpatient visits and 39% of all telehealth services. What effect does this have on psychiatric practice?

Here’s why educators are walking away from the profession they love.

New data shows a decrease in life expectancy in the United States. Here’s why.

What are the challenges and opportunities for improvement in COVID-19-related mental health care?

What are the long term psychiatric and neuropsychiatric complications of COVID-19?